Pressure Surface denied as experimental or investigational by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for pressure surface are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied a Pressure-Relieving Surface as Experimental

An "experimental or investigational" denial from Blue Cross Blue Shield (BCBS) for a pressure-relieving support surface is unusual but does occur — most often when the specific type of surface requested (for example, a powered air-fluidized bed, a continuous lateral rotation mattress, or an advanced reactive surface) is not separately addressed in BCBS's medical policy, or when a newer surface technology has not yet been incorporated into a plan's coverage criteria. It can also arise when the diagnostic context is uncommon and the plan's reviewer did not find a recognized evidence base for that specific application.

## Why This Denial Is Appealable

Pressure-relieving surfaces for prevention and treatment of pressure injuries are addressed in published clinical guidelines from the National Pressure Injury Advisory Panel (NPIAP) and in CMS coverage frameworks (which many BCBS policies incorporate by reference). If the requested surface type is recognized by these bodies as appropriate for your pressure-injury stage or risk level, the "experimental" characterization is inconsistent with the prevailing standard of care and should be challenged. The burden is on BCBS to demonstrate that their policy's experimental criterion is correctly applied to your specific situation.

## Federal Appeal Framework

• Internal appeal (ACA §2719 / ERISA §503): You have the right to a full-and-fair internal review. The denial notice states the appeal deadline — preserve it and act before it lapses.
• External review: If the internal appeal is denied, you may request independent IRO review at no cost, generally within four months of the final denial. Expedited review (72-hour turnaround) is available when delay would seriously jeopardize your health or ability to regain maximum function.
• Medicare Advantage note: If your BCBS plan is a Medicare Advantage product, CMS-specific appeal rights and the QIC review pathway also apply.
• State insurance law: Some states require that experimental-use determinations follow specific evidentiary standards; check your state's requirements or contact your state insurance commissioner.

## Concrete Appeal Process and Timeline

1. Request BCBS's medical coverage policy for the specific surface type that was denied, including the experimental/investigational criteria being applied. 2. Have your wound-care clinician or prescriber gather evidence supporting standard-of-care status for this surface type in your clinical context. 3. Submit a formal internal appeal with all documentation. 4. If denied at the internal level, file for external IRO review within the stated window.

## Documentation to Gather

• Wound/pressure-injury assessment: Comprehensive current documentation of wound stage, anatomical location, tissue characteristics, and progression or failure to heal — performed and dated by a qualified wound-care specialist or physician.
• Standard-of-care support: A prescriber or wound-care specialist letter explaining that the requested surface type is consistent with published NPIAP guidelines and recognized clinical practice for your wound stage and clinical situation — naming the guideline organization without citing specific numbers.
• Prior surface trials: Documentation of surfaces already tried, with dates, outcomes, and reasons for inadequacy — this demonstrates that the requested surface is not a first-line speculative choice.
• Clinical context: Records of comorbidities (such as immobility, neurological conditions, or nutritional status) that support the medical necessity of the specific surface type requested.
• BCBS policy reference: The specific experimental-criterion language from BCBS's coverage policy, so the appeal can address each element directly.

## Criteria-Mapping Structure

For each experimental/investigational criterion BCBS applies:

| BCBS Experimental Criterion | Clinical or Guideline Rebuttal | |---|---| | [Copy exact language from denial or BCBS policy] | [Wound assessment finding, guideline org reference, prescriber attestation, or prior-trial outcome] |

A well-documented rebuttal that maps to BCBS's own policy language — supported by a wound-care specialist's clinical narrative — is the most effective instrument for overturning an experimental denial for a durable medical equipment item.